| Peer-Reviewed

Comparison of Hernia Recurrence and Seroma Formation in Cancer Patients Undergoing Incisional Hernia Repair with Transfascial Sutures vs. Fibrin Glue for Mesh Fixation

Received: 15 February 2021    Accepted: 25 February 2021    Published: 4 March 2021
Views:       Downloads:
Abstract

Background: Open ventral incisional hernia repairs with mesh reduce hernia recurrence rates to less than 10%. The Rives-Stoppa retrorectus hernia repair technique is becoming the standard of care for mesh repair of complex incisional hernias. In these hernia repairs, mesh has traditionally been fixated with transfascial sutures, but fibrin glue has been used as an alternative to reduce pain and may also reduce operative time and the risk of seroma formation. The primary objective of this study was to compare the rates of hernia recurrence and seroma formation in cancer patients who underwent Rives-Stoppa incisional hernia repair using transfascial sutures vs. fibrin glue for mesh fixation. Methods: We conducted a retrospective review of a prospectively maintained database of cancer patients at our free-standing cancer institution who underwent Rives-Stoppa ventral incisional hernia repair performed at our institution. Fisher’s exact test was used to assess differences in hernia recurrence and seroma formation rates between patients who underwent mesh fixation with transfascial sutures vs. fibrin glue. Using a neutral prior probability distribution, a Bayesian analysis was performed to evaluate the posterior probability of seroma formation requiring intervention and hernia recurrence after retrorectus repair with fibrin glue fixation. Log-rank test was used to assess the difference in overall survival between the two groups. Results: Forty-one patients (22 in the transfascial suture group and 19 in the fibrin glue group) were included in the analysis. The patient demographics were similar in both groups. There was no statistically significant difference in seroma formation requiring drainage by interventional radiology (IR) between the fibrin glue and the transfascial suture groups (5.3% vs. 9.1%; P=1.00). The odds of having a hernia recurrence was 4 times higher in the transfascial suture group than in the fibrin glue fixation group, but this was not statistically significant (18.2% vs 5.3%, p=0.35). The Bayesian analysis showed a 90% probability that the hernia recurrence rate would be higher in the transfascial suture than in the fibrin glue fixation group. Conclusion: Using fibrin glue instead of transfascial sutures may reduce hernia recurrences and seroma formation in cancer patients undergoing ventral incisional hernia repairs with retro rectus mesh. The high probability of reducing the odds of hernia recurrence with fibrin glue fixation warrants a prospective randomized, multi-institutional clinical trial.

Published in International Journal of Clinical Oncology and Cancer Research (Volume 6, Issue 1)
DOI 10.11648/j.ijcocr.20210601.17
Page(s) 42-48
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Ventral Incisional Hernia, Rives-Stoppa Technique, Fibrin Glue, Seroma, Hernia Recurrence

References
[1] Santora, T. A. and J. J. Roslyn, Incisional hernia. Surg Clin North Am, 1993. 73 (3): p. 557-70.
[2] Pauli, E. M. and M. J. Rosen, Open ventral hernia repair with component separation. Surg Clin North Am, 2013. 93 (5): p. 1111-33.
[3] Millikan, K. W., Incisional hernia repair. Surg Clin North Am, 2003. 83 (5): p. 1223-34.
[4] El-Gazzaz, G., et al., Risk of infection and hernia recurrence for patients undergoing ventral hernia repair with non-absorbable or biological mesh during open bowel procedures. Tech Coloproctol, 2013. 17 (3): p. 315-20.
[5] Gronnier, C., et al., Risk factors for chronic pain after open ventral hernia repair by underlay mesh placement. World J Surg, 2012. 36 (7): p. 1548-54.
[6] McLanahan, D., et al., Retrorectus prosthetic mesh repair of midline abdominal hernia. Am J Surg, 1997. 173 (5): p. 445-9.
[7] Vermeulen, J., I. Alwayn, and L. P. Stassen, Prolonged abdominal wall pain caused by transfascial sutures used in the laparoscopic repair of incisional hernia. Surg Endosc, 2003. 17 (9): p. 1497.
[8] Chevrel, J. a. R. A., The Use of Fibrin Glues in the Surgical Treatment of Incisional Hernias. Hernia 1997. 1: p. 9-14.
[9] Rhemtulla, I., et al. Retromuscular Mesh Repair Using Fibrin Glue: Early Outcomes and Cost-effectiveness of an Evolving Technique. Plastic Reconstr Surg Glob Open, 2019. Apr; 7 (4): e2184
[10] Chandra, P., D. Phalgune, and S. Shah, Comparison of the Clinical Outcome and Complications in Laparoscopic Hernia Repair of Inguinal Hernia With Mesh Fixation Using Fibrin Glue vs Tacker. Indian J Surg, 2016. 78 (6): p. 464-470.
[11] Fortelny, R. H., et al., Use of fibrin sealant (Tisseel/Tissucol) in hernia repair: a systematic review. Surg Endosc, 2012. 26 (7): p. 1803-12.
[12] Moazzez, A. and E. D. Dubina, A Novel Approach to Mesh Fixation in Retrorectus Ventral Hernia Repair Using Fibrin Sealant. J Am Coll Surg, 2017. 225 (3): p. e1-e4.
[13] Morales-Conde, S., et al., Influence of fibrin sealant in preventing postoperative seroma and normalizing the abdominal wall after laparoscopic repair of ventral hernia. Surg Endosc, 2013. 27 (9): p. 3214-9.
[14] Kohler, G., et al., Prevention of subcutaneous seroma formation in open ventral hernia repair using a new low-thrombin fibrin sealant. World J Surg, 2014. 38 (11): p. 2797-803.
[15] Fernández Lobato, R., et al., Tissucol application in dermolipectomy and incisional hernia repair. Int Surg, 2001. 86 (4): p. 240-5.
Cite This Article
  • APA Style

    Celia Ledet, David Santos, Xuemei Wang, Heather Gibson, Angela Limmer, et al. (2021). Comparison of Hernia Recurrence and Seroma Formation in Cancer Patients Undergoing Incisional Hernia Repair with Transfascial Sutures vs. Fibrin Glue for Mesh Fixation. International Journal of Clinical Oncology and Cancer Research, 6(1), 42-48. https://doi.org/10.11648/j.ijcocr.20210601.17

    Copy | Download

    ACS Style

    Celia Ledet; David Santos; Xuemei Wang; Heather Gibson; Angela Limmer, et al. Comparison of Hernia Recurrence and Seroma Formation in Cancer Patients Undergoing Incisional Hernia Repair with Transfascial Sutures vs. Fibrin Glue for Mesh Fixation. Int. J. Clin. Oncol. Cancer Res. 2021, 6(1), 42-48. doi: 10.11648/j.ijcocr.20210601.17

    Copy | Download

    AMA Style

    Celia Ledet, David Santos, Xuemei Wang, Heather Gibson, Angela Limmer, et al. Comparison of Hernia Recurrence and Seroma Formation in Cancer Patients Undergoing Incisional Hernia Repair with Transfascial Sutures vs. Fibrin Glue for Mesh Fixation. Int J Clin Oncol Cancer Res. 2021;6(1):42-48. doi: 10.11648/j.ijcocr.20210601.17

    Copy | Download

  • @article{10.11648/j.ijcocr.20210601.17,
      author = {Celia Ledet and David Santos and Xuemei Wang and Heather Gibson and Angela Limmer and Brian Badgwell},
      title = {Comparison of Hernia Recurrence and Seroma Formation in Cancer Patients Undergoing Incisional Hernia Repair with Transfascial Sutures vs. Fibrin Glue for Mesh Fixation},
      journal = {International Journal of Clinical Oncology and Cancer Research},
      volume = {6},
      number = {1},
      pages = {42-48},
      doi = {10.11648/j.ijcocr.20210601.17},
      url = {https://doi.org/10.11648/j.ijcocr.20210601.17},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcocr.20210601.17},
      abstract = {Background: Open ventral incisional hernia repairs with mesh reduce hernia recurrence rates to less than 10%. The Rives-Stoppa retrorectus hernia repair technique is becoming the standard of care for mesh repair of complex incisional hernias. In these hernia repairs, mesh has traditionally been fixated with transfascial sutures, but fibrin glue has been used as an alternative to reduce pain and may also reduce operative time and the risk of seroma formation. The primary objective of this study was to compare the rates of hernia recurrence and seroma formation in cancer patients who underwent Rives-Stoppa incisional hernia repair using transfascial sutures vs. fibrin glue for mesh fixation. Methods: We conducted a retrospective review of a prospectively maintained database of cancer patients at our free-standing cancer institution who underwent Rives-Stoppa ventral incisional hernia repair performed at our institution. Fisher’s exact test was used to assess differences in hernia recurrence and seroma formation rates between patients who underwent mesh fixation with transfascial sutures vs. fibrin glue. Using a neutral prior probability distribution, a Bayesian analysis was performed to evaluate the posterior probability of seroma formation requiring intervention and hernia recurrence after retrorectus repair with fibrin glue fixation. Log-rank test was used to assess the difference in overall survival between the two groups. Results: Forty-one patients (22 in the transfascial suture group and 19 in the fibrin glue group) were included in the analysis. The patient demographics were similar in both groups. There was no statistically significant difference in seroma formation requiring drainage by interventional radiology (IR) between the fibrin glue and the transfascial suture groups (5.3% vs. 9.1%; P=1.00). The odds of having a hernia recurrence was 4 times higher in the transfascial suture group than in the fibrin glue fixation group, but this was not statistically significant (18.2% vs 5.3%, p=0.35). The Bayesian analysis showed a 90% probability that the hernia recurrence rate would be higher in the transfascial suture than in the fibrin glue fixation group. Conclusion: Using fibrin glue instead of transfascial sutures may reduce hernia recurrences and seroma formation in cancer patients undergoing ventral incisional hernia repairs with retro rectus mesh. The high probability of reducing the odds of hernia recurrence with fibrin glue fixation warrants a prospective randomized, multi-institutional clinical trial.},
     year = {2021}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Comparison of Hernia Recurrence and Seroma Formation in Cancer Patients Undergoing Incisional Hernia Repair with Transfascial Sutures vs. Fibrin Glue for Mesh Fixation
    AU  - Celia Ledet
    AU  - David Santos
    AU  - Xuemei Wang
    AU  - Heather Gibson
    AU  - Angela Limmer
    AU  - Brian Badgwell
    Y1  - 2021/03/04
    PY  - 2021
    N1  - https://doi.org/10.11648/j.ijcocr.20210601.17
    DO  - 10.11648/j.ijcocr.20210601.17
    T2  - International Journal of Clinical Oncology and Cancer Research
    JF  - International Journal of Clinical Oncology and Cancer Research
    JO  - International Journal of Clinical Oncology and Cancer Research
    SP  - 42
    EP  - 48
    PB  - Science Publishing Group
    SN  - 2578-9511
    UR  - https://doi.org/10.11648/j.ijcocr.20210601.17
    AB  - Background: Open ventral incisional hernia repairs with mesh reduce hernia recurrence rates to less than 10%. The Rives-Stoppa retrorectus hernia repair technique is becoming the standard of care for mesh repair of complex incisional hernias. In these hernia repairs, mesh has traditionally been fixated with transfascial sutures, but fibrin glue has been used as an alternative to reduce pain and may also reduce operative time and the risk of seroma formation. The primary objective of this study was to compare the rates of hernia recurrence and seroma formation in cancer patients who underwent Rives-Stoppa incisional hernia repair using transfascial sutures vs. fibrin glue for mesh fixation. Methods: We conducted a retrospective review of a prospectively maintained database of cancer patients at our free-standing cancer institution who underwent Rives-Stoppa ventral incisional hernia repair performed at our institution. Fisher’s exact test was used to assess differences in hernia recurrence and seroma formation rates between patients who underwent mesh fixation with transfascial sutures vs. fibrin glue. Using a neutral prior probability distribution, a Bayesian analysis was performed to evaluate the posterior probability of seroma formation requiring intervention and hernia recurrence after retrorectus repair with fibrin glue fixation. Log-rank test was used to assess the difference in overall survival between the two groups. Results: Forty-one patients (22 in the transfascial suture group and 19 in the fibrin glue group) were included in the analysis. The patient demographics were similar in both groups. There was no statistically significant difference in seroma formation requiring drainage by interventional radiology (IR) between the fibrin glue and the transfascial suture groups (5.3% vs. 9.1%; P=1.00). The odds of having a hernia recurrence was 4 times higher in the transfascial suture group than in the fibrin glue fixation group, but this was not statistically significant (18.2% vs 5.3%, p=0.35). The Bayesian analysis showed a 90% probability that the hernia recurrence rate would be higher in the transfascial suture than in the fibrin glue fixation group. Conclusion: Using fibrin glue instead of transfascial sutures may reduce hernia recurrences and seroma formation in cancer patients undergoing ventral incisional hernia repairs with retro rectus mesh. The high probability of reducing the odds of hernia recurrence with fibrin glue fixation warrants a prospective randomized, multi-institutional clinical trial.
    VL  - 6
    IS  - 1
    ER  - 

    Copy | Download

Author Information
  • Departments of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

  • Departments of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

  • Departments of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

  • Departments of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

  • Departments of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

  • Departments of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

  • Sections